Business & Industry

The medicine manufacturers from Europe are bracing for President Donald Trump’s plan to slap tariffs of almost 250% on medicine imported from the EU. The declaration made by Trump that the drug exports of Europe will be hit with certain...

Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel the United States to the forefront of global AI leadership. Within its three pillars—innovation, infrastructure,...

The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that are participating in the 340B drugs discount program. The pilot happens to depart from the...

President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been posted by Trump on social media Say name-brand drug prices are almost three times...

Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms Permira and Nordic Capital. Apparently, the board of directors of the company plan to unanimously...

The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of almost $8 billion in 2025 year-to-date. It has emerged as a biopharma innovation hub...

Finally, the Trump administration’s much-animated tariffs on pharmaceutical imports are now materializing in a new EU-US trade deal. However, there are still many questions that remain. As part of a trade agreement that was reached between the US and the...